We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




World’s First One-Minute Hepatitis C Antibody Test Facilitates Quick Triage

By LabMedica International staff writers
Posted on 21 May 2024
Print article
Image: The INSTI HCV Antibody Test is the world’s first one minute test (Photo courtesy of bioLytical Laboratories)
Image: The INSTI HCV Antibody Test is the world’s first one minute test (Photo courtesy of bioLytical Laboratories)

Rapid and accurate testing is crucial in the fight against Hepatitis C. Having regular access to testing helps ensure the prompt identification of potential Hepatitis C infections and facilitates immediate linkage to care, thus helping to reduce further transmission. Now, the first one-minute Hepatitis C antibody test can prove to be an excellent tool in managing this disease.

The INSTI HCV Antibody Test from bioLytical Laboratories (Richmond, BC, Canada) is the world’s first one-minute test that detects antibodies to the Hepatitis C virus, which are substances released into the bloodstream upon infection. The test includes procedural control for IgG and IgM and can identify HCV genotypes 1 through 6, delivering results in as little as 60 seconds. It is both highly accurate and affordable, designed for ease of use. This fully portable system does not require any additional equipment, enabling healthcare providers to conduct tests in various settings, from clinical laboratories to remote testing locations.

By providing results in one minute or less, the INSTI HCV Antibody Test supports rapid triage and facilitates quick access to treatment. Its quick turnaround is ideal for integration into diverse healthcare workflows. The test is simple to administer via a simple finger prick and requires minimal training, making it adaptable to a variety of settings, including clinics and emergency environments. By eliminating the need for venepuncture, the INSTI HCV Antibody Test reduces delays in treatment and improves the connection to subsequent care and treatment, meeting a critical clinical need.

“Our INSTI HCV Antibody Test provides a rapid and reliable tool to identify hepatitis C cases quickly, helping healthcare professionals test high-risk populations and reduce transmission,” said Robert Mackie, bioLytical CEO.

Related Links:
bioLytical Laboratories

New
Gold Member
ZIKA Virus Test
ZIKA ELISA IgG
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
New
Procalcitonin Rapid Test
StrongStep Procalcitonin Test
New
Enterovirus Infection Test
Virotech Enterovirus IgM ELISA Kit

Print article

Channels

Immunology

view channel
Image: Example image of the high-throughput microscopy method used in the study, showing immune cells stained with different fluorescence markers (Photo courtesy of Felix Kartnig/CeMM, MedUni Vienna)

Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies

Rheumatoid arthritis is the most common inflammatory joint disorder, with women three times as likely to suffer from the condition as men. Treatment advances made over the past decades have led to the... Read more

Microbiology

view channel
Image: RNA sequencing directly from whole blood aims to expand access to LRTI testing (Photo courtesy of CARB-X)

Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood

Pneumonia and lower-respiratory-tract infections (LRTIs) are among the top causes of illness and death globally, particularly in vulnerable populations such as the elderly, young children, and immunocompromised... Read more

Pathology

view channel
Image: Lunit SCOPE HER2 is an AI-powered solution designed to detect HER2 expression profile (Photo courtesy of Lunit)

AI-Powered Pathology Solutions Accurately Predict Outcomes for HER2-Targeted Therapy in Metastatic CRC

A new study has highlighted how artificial intelligence (AI)-powered analysis of HER2 and the tumor microenvironment (TME) can improve patient stratification and predict clinical outcomes more effectively.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.